Cargando…

Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes

AIMS/INTRODUCTION: Senescence marker protein-30 (SMP30) is abundantly expressed in renal proximal tubule cells, but its expression decreases with age. Previous studies have shown that reduced SMP30 expression could contribute to aging-associated deterioration of cellular function and tissue injury....

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Hiroshi, Senmaru, Takafumi, Fukui, Michiaki, Kondo, Yoshitaka, Ishigami, Akihito, Maruyama, Naoki, Obayashi, Hiroshi, Yamazaki, Masahiro, Nakamura, Naoto, Hasegawa, Goji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296701/ https://www.ncbi.nlm.nih.gov/pubmed/25621131 http://dx.doi.org/10.1111/jdi.12252

Ejemplares similares

Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Lepr(db/db) Mice with Senescence Marker Protein-30 Knockout (Lepr(db/db)Smp30(Y/−)) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet
por: Kondo, Yoshitaka, et al.
Publicado: (2013)

Structural Basis of the γ-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase
por: Aizawa, Shingo, et al.
Publicado: (2013)

Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
por: Okada, Hiroshi, et al.
Publicado: (2013)

Dipeptidyl‐peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
por: Kitae, Aya, et al.
Publicado: (2020)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetes
por: Matsumoto, Shinobu, et al.
Publicado: (2013)

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
por: Hamaguchi, Masahide, et al.
Publicado: (2022)

Usefulness of Exercise for Home Blood Pressure Control in People with Diabetes: A Study Protocol for a Crossover Randomized Controlled Trial
por: Iwai, Keiko, et al.
Publicado: (2020)

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
por: Okamura, Takuro, et al.
Publicado: (2021)

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
por: Takewaki, Fumie, et al.
Publicado: (2021)

Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease
por: Okada, Hiroshi, et al.
Publicado: (2015)

Usefulness of Aerobic Exercise for Home Blood Pressure Control in Patients with Diabetes: Randomized Crossover Trial
por: Iwai, Keiko, et al.
Publicado: (2022)

Atrophic gastritis is associated with coronary artery disease
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes
por: Kimura, Tomonori, et al.
Publicado: (2020)

Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes
por: Nakajima, Hanako, et al.
Publicado: (2023)

Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers
por: Yamazaki, Masahiro, et al.
Publicado: (2014)

The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA‐HBP study
por: Okamura, Takuro, et al.
Publicado: (2019)

Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
por: Takegami, Maya, et al.
Publicado: (2022)

Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Hasegawa, Yuka, et al.
Publicado: (2021)

Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy
por: Okamura, Takuro, et al.
Publicado: (2021)

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy
por: Han, Yachun, et al.
Publicado: (2021)

Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD Rhapsody(TM) VDJ CDR3 Assay
por: Okamura, Takuro, et al.
Publicado: (2022)

Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Eating Speed Is Associated with the Presence of Sarcopenia in Older Patients with Type 2 Diabetes: A Cross-Sectional Study of the KAMOGAWA-DM Cohort
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort
por: Kobayashi, Genki, et al.
Publicado: (2022)

Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial
por: Hata, Shinnosuke, et al.
Publicado: (2021)

Dental care and oral conditions are associated with the prevalence of sarcopenia in people with type 2 diabetes: a cross-sectional study
por: Takahashi, Fuyuko, et al.
Publicado: (2023)

Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance
por: Okamura, Takuro, et al.
Publicado: (2021)

Association between Geriatric Nutrition Risk Index and The Presence of Sarcopenia in People with Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2020)

Association of Estimated Salt and Miso Intake with the Prevalence of Obesity in People with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
por: Sugita, Erina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4ok5gogcf7g14th8rdl1vmqab